Search

Search Constraints

You searched for: Author/Creator Han, Misop

Search Results

2. Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?. Issue 9 (9th December 2014)

3. Outcomes of very high‐risk prostate cancer after radical prostatectomy: Validation study from 3 centers. Issue 3 (13th November 2018)

4. Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer. (27th January 2019)

8. Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium. Issue 1 (26th January 2022)

9. The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy. (14th July 2022)

10. Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy. Issue 6 (25th December 2022)